Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mairead MacKenzie
ADD-ASPIRIN: A Phase III, Double-Blind, Placebo Controlled, Randomised Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non-Metastatic Solid Tumours
Contemporary Clinical Trials
Medicine
Pharmacology
Related publications
Aspirin for Prophylaxis Against Headache at High Altitudes: Randomised, Double Blind, Placebo Controlled Trial
BMJ
Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
The Lancet
Medicine
Misoprostol for Small Bowel Ulcers in Patients With Obscure Bleeding Taking Aspirin and Non-Steroidal Anti-Inflammatory Drugs (MASTERS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Gastroenterology and Hepatology, The
Hepatology
Gastroenterology
A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Safety and Efficacy of Co-Careldopa as an Add-On Therapy to Occupational and Physical Therapy in Patients After Stroke (DARS): A Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet Neurology
Neurology
Tocilizumab in Patients With Adult-Onset Still’s Disease Refractory to Glucocorticoid Treatment: A Randomised, Double-Blind, Placebo-Controlled Phase III Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Adjuvant Imatinib Mesylate After Resection of Localised, Primary Gastrointestinal Stromal Tumour: A Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet
Medicine
